|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
EXP
|
ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:21871475 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
EXP
|
ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:21871475 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Pdgfb
|
platelet derived growth factor subunit B
|
multiple interactions
|
EXP
|
ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of MAPK1 protein]; ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of MAPK3 protein]; ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PDGFRB protein]; ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PLCG1 protein]
|
CTD |
PMID:21871475 |
|
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
multiple interactions
|
EXP
|
ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PDGFRB protein]
|
CTD |
PMID:21871475 |
|
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Plcg1
|
phospholipase C, gamma 1
|
multiple interactions
|
EXP
|
ampelopsin analog inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PLCG1 protein]
|
CTD |
PMID:21871475 |
|
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
|
|
| G
|
Sphk1
|
sphingosine kinase 1
|
decreases expression decreases activity
|
ISO
|
ampelopsin results in decreased expression of SPHK1 protein ampelopsin results in decreased activity of SPHK1 protein
|
CTD |
PMID:22251058 |
|
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082
|
|
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
Diosmin binds to and results in increased activity of AHR protein
|
CTD |
PMID:14644660 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of AR protein]
|
CTD |
PMID:31797688 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of BAD protein]
|
CTD |
PMID:21477647 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein]
|
CTD |
PMID:32061149 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
EXP ISO
|
[Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]
|
CTD |
PMID:21477647 PMID:32061149 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions
|
EXP ISO
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP3 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of CASP3 protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]
|
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 PMID:32061149 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein]
|
CTD |
PMID:23665045 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of CAT protein]; Diosmin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; Diosmin inhibits the reaction [Testosterone Propionate results in decreased activity of CAT protein]
|
CTD |
PMID:22056647 PMID:23665045 PMID:31797688 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ceacam1
|
CEA cell adhesion molecule 1
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of CEACAM1 protein]
|
CTD |
PMID:35920545 |
|
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of CREB1 protein]
|
CTD |
PMID:35920545 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP2E1 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Eno2
|
enolase 2
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein]
|
CTD |
PMID:35920545 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of and results in decreased activity of GPX1 protein]
|
CTD |
PMID:35920545 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP ISO
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of GSR protein]; Diosmin inhibits the reaction [Testosterone Propionate results in decreased activity of GSR protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSR protein]
|
CTD |
PMID:23665045 PMID:31797688 PMID:32061149 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO EXP
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of IL6 protein] Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of IL6 protein]
|
CTD |
PMID:31797688 PMID:32061149 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of KLK3 protein]
|
CTD |
PMID:31797688 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [Acetic Acid results in increased activity of MPO protein]
|
CTD |
PMID:29187079 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of PARP1 protein]
|
CTD |
PMID:32061149 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Ptger2
|
prostaglandin E receptor 2
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGER2 protein]
|
CTD |
PMID:35920545 |
|
NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
EXP ISO
|
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of PTGS2 protein]; Diosmin inhibits the reaction [Testosterone Propionate results in increased expression of PTGS2 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein]
|
CTD |
PMID:23665045 PMID:29187079 PMID:31797688 PMID:32061149 PMID:35920545 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of RELA protein]
|
CTD |
PMID:32061149 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of TNF protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of TNF protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
|
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
EXP
|
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
multiple interactions
|
EXP ISO
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of XDH protein]; Diosmin inhibits the reaction [Testosterone Propionate results in increased activity of XDH protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of XDH protein]
|
CTD |
PMID:23665045 PMID:31797688 PMID:32061149 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
EXP
|
[bisphenol A diglycidyl ether co-treated with Hesperidin] inhibits the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in increased activity of ACHE protein]; Hesperidin inhibits the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in increased activity of ACHE protein]
|
CTD |
PMID:32627286 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
multiple interactions
|
EXP
|
hesperidin inhibits the reaction [ethanol increases expression of alpha SMA protein in liver parenchyma]
|
RGD |
PMID:28320086 |
RGD:598130086 |
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Afp
|
alpha-fetoprotein
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of AFP protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein]
|
CTD |
PMID:28935427 PMID:30779474 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in decreased activity of AKT1 protein]
|
CTD |
PMID:30779474 PMID:35413380 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of AKT2 mRNA] Hesperidin results in increased expression of AKT2 mRNA
|
CTD |
PMID:36966900 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Alb
|
albumin
|
multiple interactions increases expression
|
ISO EXP
|
[Hesperidin co-treated with Doxorubicin] results in increased expression of ALB protein Hesperidin inhibits the reaction [Dichlorvos results in decreased expression of ALB protein] Hesperidin results in increased expression of ALB protein
|
CTD |
PMID:29481770 PMID:39733793 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Atf6
|
activating transcription factor 6
|
multiple interactions decreases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ATF6 mRNA] Hesperidin results in decreased expression of ATF6 mRNA
|
CTD |
PMID:34748272 PMID:35413380 PMID:36966900 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP ISO
|
[Hesperidin co-treated with Chlorpyrifos] results in increased expression of BAX mRNA; Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein]]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BAX protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of BAX mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of BAX protein]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAX protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of BAX mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of BAX protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of BAX mRNA] Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]] Doxorubicin promotes the reaction [Hesperidin results in increased expression of BAX mRNA]
|
CTD |
PMID:24954035 PMID:29481770 PMID:32050098 PMID:33908150 PMID:34748272 PMID:35413380 PMID:35921949 PMID:36966900 PMID:39987982 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
EXP ISO
|
[Hesperidin co-treated with Chlorpyrifos] results in decreased expression of BCL2 mRNA; Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]; Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Finasteride results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA] Hesperidin inhibits the reaction [TNF protein results in decreased expression of BCL2 protein] Hesperidin results in decreased expression of BCL2 mRNA Doxorubicin promotes the reaction [Hesperidin results in decreased expression of BCL2 mRNA]
|
CTD |
PMID:22093918 PMID:24954035 PMID:29481770 PMID:30623541 PMID:32050098 PMID:33908150 PMID:34748272 PMID:35413380 PMID:35921949 PMID:36966900 PMID:38216069 PMID:39987982 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Becn1
|
beclin 1
|
multiple interactions decreases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of BECN1 protein]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of BECN1 protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of BECN1 protein] Hesperidin results in decreased expression of BECN1 protein
|
CTD |
PMID:33908150 PMID:34748272 PMID:35413380 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
increases expression
|
EXP
|
Hesperidin results in increased expression of BMP2 mRNA
|
CTD |
PMID:21820093 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions decreases expression increases activity increases expression
|
EXP ISO
|
[Hesperidin co-treated with Chlorpyrifos] results in increased expression of CASP3 mRNA; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [Dichlorvos results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [Finasteride results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of CASP3 mRNA]; Hesperidin promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 protein] Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]] Hesperidin results in decreased expression of CASP3 protein [Hesperidin co-treated with Doxorubicin] results in increased activity of CASP3 protein; Doxorubicin promotes the reaction [Hesperidin results in increased expression of CASP3 mRNA] Hesperidin results in increased activity of CASP3 protein
|
CTD |
PMID:22093918 PMID:29481770 PMID:30066062 PMID:30623541 PMID:30779474 PMID:33908150 PMID:34748272 PMID:35413380 PMID:35921949 PMID:36966900 PMID:38216069 PMID:39733793 PMID:39987982 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 protein]
|
CTD |
PMID:22093918 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity increases activity
|
EXP ISO
|
Hesperidin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [abamectin results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Acetic Acid results in increased activity of CAT protein]; Hesperidin inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CAT protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Finasteride results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]; Hesperidin inhibits the reaction [Paclitaxel results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in decreased activity of CAT protein] Hesperidin results in decreased activity of CAT protein Hesperidin results in increased activity of CAT protein Hesperidin inhibits the reaction [Doxorubicin results in increased activity of CAT protein]
|
CTD |
PMID:22093918 PMID:29481770 PMID:30066062 PMID:30098279 PMID:30623541 PMID:30779474 PMID:31095933 PMID:32050098 PMID:33003968 PMID:33908150 PMID:34748272 PMID:35413380 PMID:36966900 PMID:39733793 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of CCL3 protein]; Hesperidin inhibits the reaction [Ethanol results in increased expression of CCL3 protein]
|
CTD |
PMID:30368987 PMID:30811821 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]]
|
CTD |
PMID:39987982 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]]
|
CTD |
PMID:39987982 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions decreases expression
|
ISO
|
BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CCND1 mRNA]; BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CCND1 protein]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CCND1 mRNA]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CCND1 protein] Hesperidin results in decreased expression of CCND1 mRNA; Hesperidin results in decreased expression of CCND1 protein
|
CTD |
PMID:34984768 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylnitrosamine results in increased expression of CDK2 protein]
|
CTD |
PMID:30779474 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions decreases expression
|
ISO
|
BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CDK4 mRNA]; BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CDK4 protein]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CDK4 mRNA]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CDK4 protein] Hesperidin results in decreased expression of CDK4 mRNA; Hesperidin results in decreased expression of CDK4 protein
|
CTD |
PMID:34984768 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk6
|
cyclin-dependent kinase 6
|
decreases expression multiple interactions
|
ISO
|
Hesperidin results in decreased expression of CDK6 mRNA; Hesperidin results in decreased expression of CDK6 protein BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CDK6 mRNA]; BIX 02189 promotes the reaction [Hesperidin results in decreased expression of CDK6 protein]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CDK6 mRNA]; Hesperidin promotes the reaction [BIX 02189 results in decreased expression of CDK6 protein]
|
CTD |
PMID:34984768 |
|
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO
|
BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1A mRNA]; BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1A protein] Hesperidin results in increased expression of CDKN1A mRNA; Hesperidin results in increased expression of CDKN1A protein
|
CTD |
PMID:34984768 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
multiple interactions increases expression
|
ISO
|
BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B mRNA]; BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B protein] Hesperidin results in increased expression of CDKN1B mRNA; Hesperidin results in increased expression of CDKN1B protein
|
CTD |
PMID:34984768 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]]
|
CTD |
PMID:39987982 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]
|
CTD |
PMID:17400256 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of EIF2AK3 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of EIF2AK3 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of EIF2AK3 mRNA] Hesperidin results in increased expression of EIF2AK3 mRNA
|
CTD |
PMID:34748272 PMID:35413380 PMID:36966900 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of ERN1 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ERN1 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ERN1 mRNA]
|
CTD |
PMID:34748272 PMID:35413380 PMID:36966900 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Fabp9
|
fatty acid binding protein 9
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in increased secretion of FABP9 protein]
|
CTD |
PMID:32050098 |
|
NCBI chr 2:93,499,136...93,503,267
Ensembl chr 2:93,499,134...93,503,260
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
Hesperidin affects the reaction [LEPR protein affects the activity of FASN protein]
|
CTD |
PMID:16427799 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
G6pc3
|
glucose 6 phosphatase catalytic subunit 3
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Streptozocin results in decreased activity of G6PC3 protein]
|
CTD |
PMID:31345080 |
|
NCBI chr10:87,647,149...87,651,385
Ensembl chr10:87,647,062...87,653,453
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
decreases activity multiple interactions
|
ISO EXP
|
Hesperidin results in decreased activity of G6PD protein Hesperidin inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] Hesperidin affects the reaction [LEPR protein affects the activity of G6PD protein]
|
CTD |
PMID:16427799 PMID:25130191 PMID:31345080 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gck
|
glucokinase
|
multiple interactions
|
ISO
|
Hesperidin affects the reaction [LEPR protein affects the expression of GCK mRNA]
|
CTD |
PMID:16427799 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
decreases activity multiple interactions
|
ISO EXP
|
Hesperidin results in decreased activity of GPT protein Hesperidin inhibits the reaction [Chlorpyrifos results in increased activity of GPT protein]; Hesperidin inhibits the reaction [Dichlorvos results in increased activity of GPT protein]; Hesperidin inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein]; Hesperidin inhibits the reaction [sodium arsenite results in increased activity of GPT protein] [Doxorubicin co-treated with Hesperidin] results in decreased activity of GPT protein
|
CTD |
PMID:29481770 PMID:30066062 PMID:30779474 PMID:33908150 PMID:39733793 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of GSR protein]; Hesperidin inhibits the reaction [Acetaminophen results in decreased activity of GSR protein]
|
CTD |
PMID:22093918 PMID:30098279 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased secretion of HAVCR1 protein]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of HAVCR1 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of HAVCR1 protein]
|
CTD |
PMID:22093918 PMID:30098279 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hdac1
|
histone deacetylase 1
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to HDAC1 protein]]
|
CTD |
PMID:34800614 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
ISO EXP
|
Hesperidin affects the reaction [LEPR protein affects the activity of HMGCR protein] Hesperidin inhibits the reaction [Dichlorvos results in decreased activity of HMGCR protein]
|
CTD |
PMID:16427799 PMID:39733793 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of HMOX1 protein]; Hesperidin inhibits the reaction [abamectin results in decreased expression of HMOX1 mRNA]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HMOX1 protein]; Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:28935427 PMID:32050098 PMID:34748272 PMID:35921949 PMID:36966900 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HSD3B1 protein]
|
CTD |
PMID:32050098 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of HSPA5 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of HSPA5 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 mRNA]
|
CTD |
PMID:34748272 PMID:35413380 PMID:36966900 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [Glucose results in increased expression of ICAM1]; Hesperidin inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
|
CTD |
PMID:17400256 PMID:22074828 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Dichlorvos results in decreased expression of IL10 mRNA]
|
CTD |
PMID:39733793 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO EXP
|
Hesperidin inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Hesperidin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Hesperidin inhibits the reaction [TNF protein co-treated with and results in increased expression of IL1B protein co-treated with and results in increased expression of CXCL8 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]] Hesperidin inhibits the reaction [abamectin results in increased expression of IL1B mRNA]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of IL1B protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of IL1B mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of IL1B protein]; Hesperidin inhibits the reaction [sodium arsenite results in increased expression of IL1B protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of IL1B protein] Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
|
CTD |
PMID:17400256 PMID:30066062 PMID:33908150 PMID:34748272 PMID:35413380 PMID:35921949 PMID:36966900 PMID:39987982 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions
|
ISO
|
Hesperidin promotes the reaction [Lipopolysaccharides results in increased expression of IL4 protein]
|
CTD |
PMID:17400256 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions decreases expression
|
ISO EXP
|
Hesperidin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] hesperidin inhibits the reaction [ethanol increases expression of IL6 in liver] Hesperidin results in decreased expression of IL6 protein [naringin co-treated with Hesperidin] results in decreased expression of IL6 protein; Hesperidin inhibits the reaction [abamectin results in increased expression of IL6 mRNA]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of IL6 mRNA]; Hesperidin inhibits the reaction [sodium arsenite results in increased expression of IL6 protein]
|
CTD RGD |
PMID:17400256 PMID:21820093 PMID:30066062 PMID:30623541 PMID:34748272 PMID:35921949 PMID:28320086 More...
|
RGD:598130086 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Jak2
|
Janus kinase 2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of JAK2 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Lep
|
leptin
|
decreases expression multiple interactions
|
EXP
|
Hesperidin results in decreased expression of LEP protein [naringin co-treated with Hesperidin] results in decreased expression of LEP protein
|
CTD |
PMID:21820093 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lepr
|
leptin receptor
|
multiple interactions
|
ISO
|
Hesperidin affects the reaction [LEPR protein affects the abundance of Glucose]; Hesperidin affects the reaction [LEPR protein affects the activity of FASN protein]; Hesperidin affects the reaction [LEPR protein affects the activity of G6PD protein]; Hesperidin affects the reaction [LEPR protein affects the activity of HMGCR protein]; Hesperidin affects the reaction [LEPR protein affects the expression of GCK mRNA]; Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein]; Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A2 protein]; Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A4 protein]
|
CTD |
PMID:16427799 |
|
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3A mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of MAP1LC3A protein]
|
CTD |
PMID:34748272 PMID:35413380 PMID:35921949 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3B mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of MAP1LC3B protein]
|
CTD |
PMID:34748272 PMID:35413380 PMID:35921949 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k5
|
mitogen activated protein kinase kinase 5
|
decreases phosphorylation
|
ISO
|
Hesperidin results in decreased phosphorylation of MAP2K5 protein
|
CTD |
PMID:34984768 |
|
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:72,520,617...72,747,373
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of MAPK14 mRNA]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of MAPK14 protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAPK14 mRNA]
|
CTD |
PMID:33908150 PMID:34748272 PMID:35921949 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk7
|
mitogen-activated protein kinase 7
|
multiple interactions
|
ISO
|
BIX 02189 promotes the reaction [Hesperidin results in decreased phosphorylation of MAPK7 protein]; Hesperidin promotes the reaction [BIX 02189 results in decreased phosphorylation of MAPK7 protein]; Hesperidin results in decreased phosphorylation of and affects the localization of MAPK7 protein
|
CTD |
PMID:34984768 |
|
NCBI chr10:46,669,721...46,675,768
Ensembl chr10:46,669,721...46,675,806
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:19110045 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:19110045 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mir126b
|
microRNA 126b
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MIR126B mRNA]
|
CTD |
PMID:32050098 |
|
NCBI chr 3:29,813,174...29,813,246
|
|
| G
|
Mir181a2
|
microRNA 181a-2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MIR181A2 mRNA]
|
CTD |
PMID:32050098 |
|
NCBI chr 3:43,025,563...43,025,679
Ensembl chr 3:43,025,563...43,025,679
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MMP2 mRNA]
|
CTD |
PMID:35921949 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions decreases secretion
|
ISO EXP
|
Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein]; Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA]; Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MMP9 mRNA] Hesperidin results in decreased secretion of MMP9 protein
|
CTD |
PMID:19110045 PMID:20138977 PMID:35921949 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions decreases activity
|
EXP
|
Hesperidin inhibits the reaction [Acetic Acid results in increased activity of MPO protein] Hesperidin results in decreased activity of MPO protein
|
CTD |
PMID:31095933 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Sodium Fluoride results in decreased expression of MTOR protein]
|
CTD |
PMID:35413380 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA]; Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein]; Hesperidin inhibits the reaction [abamectin results in decreased expression of NFE2L2 mRNA]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of NFE2L2 protein]; Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of NFE2L2 mRNA] Hesperidin results in increased expression of NFE2L2 mRNA
|
CTD |
PMID:28935427 PMID:32050098 PMID:34748272 PMID:35921949 PMID:36966900 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of NFKB1 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of NFKB1 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of NFKB1 mRNA] Hesperidin results in increased expression of NFKB1 mRNA
|
CTD |
PMID:22093918 PMID:34748272 PMID:35921949 PMID:36966900 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]]
|
CTD |
PMID:39987982 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
EXP ISO
|
Hesperidin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; Hesperidin inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of NOS2 protein] Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
|
CTD |
PMID:12512693 PMID:22093918 PMID:33908150 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
EXP
|
[Hesperidin co-treated with Chlorpyrifos] results in increased expression of PARP1 mRNA; [Hesperidin co-treated with Chlorpyrifos] results in increased expression of PARP1 protein; Hesperidin inhibits the reaction [Ethanol results in increased activity of PARP1 protein]
|
CTD |
PMID:30368987 PMID:33908150 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of PCNA protein]
|
CTD |
PMID:28935427 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylnitrosamine results in increased expression of PIK3R1 protein]
|
CTD |
PMID:30779474 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
EXP ISO
|
Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]; Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA]; Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]; Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]; Hesperidin inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein]
|
CTD |
PMID:16427799 PMID:24954035 PMID:28935427 PMID:30623541 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Dextran Sulfate results in decreased expression of PPARGC1A protein]; Hesperidin inhibits the reaction [Ethanol results in decreased expression of PPARGC1A protein]
|
CTD |
PMID:30368987 PMID:30811821 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO EXP
|
Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Hesperidin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PTGS2 protein]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of PTGS2 protein] Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:16101151 PMID:19110045 PMID:30098279 PMID:33908150 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
EXP ISO
|
Hesperidin inhibits the reaction [Dichlorvos results in increased expression of RELA mRNA]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of RELA protein] Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]; Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]]
|
CTD |
PMID:30623541 PMID:39733793 PMID:39987982 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Sgpp2
|
sphingosine-1-phosphate phosphatase 2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of SGPP2 mRNA]
|
CTD |
PMID:30811821 |
|
NCBI chr 9:87,211,155...87,331,787
Ensembl chr 9:87,211,717...87,333,132
|
|
| G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SIRT1 mRNA]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SIRT1 protein]
|
CTD |
PMID:32050098 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc1a2
|
solute carrier family 1 member 2
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to SLC1A2 promoter]]; Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein]
|
CTD |
PMID:34800614 |
|
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
multiple interactions
|
ISO
|
Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A2 protein]
|
CTD |
PMID:16427799 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
multiple interactions
|
ISO
|
Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A4 protein]
|
CTD |
PMID:16427799 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SOD2 mRNA]; Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SOD2 protein]
|
CTD |
PMID:32050098 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sphk1
|
sphingosine kinase 1
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of SPHK1 protein]
|
CTD |
PMID:30811821 |
|
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of STAT3 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tfeb
|
transcription factor EB
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Ethanol results in decreased expression of TFEB mRNA]
|
CTD |
PMID:30368987 |
|
NCBI chr 9:20,696,440...20,752,265
Ensembl chr 9:20,696,441...20,727,863
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
hesperidin inhibits the reaction [ethanol increases expression of TGFbeta protein in serum]
|
RGD |
PMID:28320086 |
RGD:598130086 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]]
|
CTD |
PMID:39987982 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnc
|
tenascin C
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [Ethanol results in increased expression of TNC protein]
|
CTD |
PMID:30368987 |
|
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases expression
|
ISO EXP
|
Hesperidin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Hesperidin inhibits the reaction [TNF protein co-treated with and results in increased expression of IL1B protein co-treated with and results in increased expression of CXCL8 protein]; Hesperidin inhibits the reaction [TNF protein results in decreased expression of BCL2 protein]; Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]; Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]; Hesperidin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]] Hesperidin results in decreased expression of TNF mRNA Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of TNF protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of TNF mRNA]; Hesperidin inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Hesperidin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of TNF mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of TNF protein]; Hesperidin inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of TNF protein] Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
|
CTD |
PMID:17400256 PMID:28935427 PMID:30066062 PMID:30623541 PMID:33908150 PMID:34748272 PMID:35413380 PMID:35921949 PMID:36966900 PMID:39987982 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf25
|
TNF receptor superfamily member 25
|
increases expression
|
ISO
|
Hesperidin results in increased expression of TNFRSF25 mRNA
|
CTD |
PMID:24633329 |
|
NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
EXP
|
Hesperidin inhibits the reaction [sodium arsenite results in increased expression of TP53 protein]
|
CTD |
PMID:30066062 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tradd
|
TNFRSF1A-associated via death domain
|
increases expression
|
ISO
|
Hesperidin results in increased expression of TRADD mRNA
|
CTD |
PMID:24633329 |
|
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
|
|
| G
|
Traf3ip2
|
Traf3 interacting protein 2
|
multiple interactions
|
ISO
|
TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]]
|
CTD |
PMID:39987982 |
|
NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions decreases expression
|
ISO
|
Hesperidin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Hesperidin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] Hesperidin results in decreased expression of VCAM1
|
CTD |
PMID:17400256 PMID:30991044 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
EXP
|
[Hesperidin co-treated with Chlorpyrifos] results in increased expression of VEGFA protein
|
CTD |
PMID:33908150 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Yy1
|
YY1 transcription factor
|
multiple interactions
|
ISO
|
Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to HDAC1 protein]]; Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to SLC1A2 promoter]]; Hesperidin inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of and affects the localization of YY1 protein]
|
CTD |
PMID:34800614 |
|
NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257
|
|
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO EXP
|
liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of CCL2 mRNA] liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of CCL2 mRNA]
|
CTD |
PMID:31589899 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
increases expression
|
ISO
|
liquiritigenin results in increased expression of CXCL12 mRNA
|
CTD |
PMID:28396216 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
liquiritigenin results in decreased activity of CYP19A1 protein
|
CTD |
PMID:38403145 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases activity
|
ISO
|
liquiritigenin results in decreased activity of CYP2C19 protein
|
CTD |
PMID:29753067 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Esr1
|
estrogen receptor 1
|
increases activity
|
ISO
|
liquiritigenin results in increased activity of ESR1 protein
|
CTD |
PMID:28396216 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
increases activity
|
ISO
|
liquiritigenin results in increased activity of ESR2 protein
|
CTD |
PMID:25106122 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLC mRNA] liquiritigenin results in increased expression of GCLC protein
|
CTD |
PMID:29908794 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
increases expression multiple interactions
|
EXP
|
liquiritigenin results in increased expression of GCLM protein liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLM mRNA]
|
CTD |
PMID:29908794 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased activity of GPT protein]
|
CTD |
PMID:31589899 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GSR mRNA]; liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GSR protein]
|
CTD |
PMID:29908794 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of HMOX1 mRNA]
|
CTD |
PMID:29908794 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
multiple interactions
|
ISO EXP
|
liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of CCL2 mRNA]; liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of IL6 mRNA]; liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of NOS2 mRNA]; liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of RELA protein] liquiritigenin inhibits the reaction [Monocrotaline affects the expression of HSPD1 protein]
|
CTD |
PMID:31589899 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO EXP
|
liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of IL6 mRNA] liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of IL6 mRNA]
|
CTD |
PMID:31589899 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein]
|
CTD |
PMID:29908794 PMID:31589899 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased activity of MPO protein]
|
CTD |
PMID:31589899 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
decreases response to substance multiple interactions
|
ISO EXP
|
NFE2L2 gene mutant form results in decreased susceptibility to liquiritigenin liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA]
|
CTD |
PMID:29908794 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
EXP ISO
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of NOS2 mRNA] liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of NOS2 mRNA]
|
CTD |
PMID:31589899 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression multiple interactions
|
ISO EXP
|
liquiritigenin results in increased expression of NQO1 protein liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NQO1 mRNA]
|
CTD |
PMID:26473469 PMID:29908794 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO EXP
|
liquiritigenin inhibits the reaction [HSPD1 protein results in increased expression of RELA protein] liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of RELA protein]
|
CTD |
PMID:31589899 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of SQSTM1 protein]
|
CTD |
PMID:29908794 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of TLR4 protein]
|
CTD |
PMID:31589899 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Trpm3
|
transient receptor potential cation channel, subfamily M, member 3
|
decreases activity
|
ISO
|
liquiritigenin results in decreased activity of TRPM3 protein
|
CTD |
PMID:25361167 |
|
NCBI chr 1:229,099,741...229,984,172
Ensembl chr 1:229,099,542...229,984,172
|
|
| G
|
Tsc22d3
|
TSC22 domain family, member 3
|
multiple interactions
|
ISO
|
liquiritigenin inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 mRNA]
|
CTD |
PMID:23183181 |
|
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:109,006,420...109,015,519
|
|
| G
|
Txn2
|
thioredoxin 2
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of TXN2 mRNA]; liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of TXN2 protein]
|
CTD |
PMID:29908794 |
|
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022
|
|
| G
|
Txnrd2
|
thioredoxin reductase 2
|
multiple interactions
|
EXP
|
liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of TXNRD2 mRNA]; liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of TXNRD2 protein]
|
CTD |
PMID:29908794 |
|
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions
|
ISO
|
naringin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]
|
CTD |
PMID:34217736 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
[naringin co-treated with Dietary Fats] results in decreased expression of ACACA mRNA
|
CTD |
PMID:22198281 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACE protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACE protein]]; naringin inhibits the reaction [bisphenol A results in increased activity of ACE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of ACE protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACE protein]
|
CTD |
PMID:32172062 PMID:32810514 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of ACHE protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in increased expression of ACHE protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACHE protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of ACHE protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ACHE protein]; naringin inhibits the reaction [bisphenol A results in increased activity of ACHE protein]; naringin inhibits the reaction [Caffeine results in increased activity of ACHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ACHE protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ACHE protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 PMID:37865952 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in decreased expression of ACOX1 mRNA]
|
CTD |
PMID:22198281 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
multiple interactions decreases expression
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA]; naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein] naringin results in decreased expression of ACP5 mRNA
|
CTD |
PMID:21835177 PMID:24376342 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Ada
|
adenosine deaminase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [bisphenol A results in increased activity of ADA protein]; naringin inhibits the reaction [Caffeine results in increased activity of ADA protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ADA protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ADA protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 PMID:37865952 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]
|
CTD |
PMID:22198281 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [AGT protein results in increased expression of CYP11B2 mRNA]; naringin inhibits the reaction [AGT protein results in increased secretion of Aldosterone]
|
CTD |
PMID:22798349 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Akr7a2
|
aldo-keto reductase family 7, member A2
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Acetaminophen results in decreased expression of AKR7A5 protein]
|
CTD |
PMID:35166444 |
|
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation
|
EXP ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased phosphorylation of AKT1 protein]; naringin inhibits the reaction [Methylprednisolone results in decreased phosphorylation of AKT1 protein]; naringin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]; plerixafor inhibits the reaction [naringin results in increased phosphorylation of AKT1 protein] naringin inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; naringin inhibits the reaction [Dexamethasone results in increased expression of AKT1 mRNA]
|
CTD |
PMID:19810018 PMID:25773745 PMID:29510123 PMID:30878453 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Angpt1
|
angiopoietin 1
|
affects expression
|
EXP
|
naringin affects the expression of ANGPT1 mRNA
|
CTD |
PMID:24880026 |
|
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression multiple interactions
|
ISO
|
naringin results in increased expression of APAF1 protein Acetylcysteine inhibits the reaction [naringin results in decreased expression of APAF1 protein]
|
CTD |
PMID:39056589 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Aqp1
|
aquaporin 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP1 mRNA]; naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP1 protein]
|
CTD |
PMID:31301536 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
| G
|
Aqp5
|
aquaporin 5
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP5 mRNA]; naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP5 protein]
|
CTD |
PMID:31301536 |
|
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062
|
|
| G
|
Atf6
|
activating transcription factor 6
|
multiple interactions increases expression
|
EXP ISO
|
naringin inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA] naringin results in increased expression of ATF6 protein
|
CTD |
PMID:38037725 PMID:39056589 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atp6v0d2
|
ATPase H+ transporting V0 subunit D2
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ATP6V0D2 mRNA]
|
CTD |
PMID:21835177 |
|
NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions
|
EXP ISO
|
naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAD mRNA] naringin inhibits the reaction [Dexamethasone results in increased phosphorylation of BAD protein]
|
CTD |
PMID:21945202 PMID:30878453 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO EXP
|
naringin results in increased expression of BAX mRNA; naringin results in increased expression of BAX protein CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]]; naringin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]; naringin inhibits the reaction [Dexamethasone results in increased expression of BAX protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of BAX protein]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]] Acetylcysteine inhibits the reaction [naringin results in increased expression of BAX protein]; naringin inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein] [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA]; naringin inhibits the reaction [Acrylamide results in increased expression of BAX protein]; naringin inhibits the reaction [Oxaliplatin results in increased expression of BAX mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of BAX protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]
|
CTD |
PMID:21945202 PMID:22847135 PMID:28422390 PMID:30130594 PMID:30878453 PMID:35166444 PMID:35179299 PMID:36598108 PMID:36811345 PMID:38037725 PMID:39056589 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased activity of BCHE protein]; naringin inhibits the reaction [bisphenol A results in increased activity of BCHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of BCHE protein]
|
CTD |
PMID:32172062 PMID:32810514 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
EXP ISO
|
[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA]; naringin inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 mRNA]; naringin inhibits the reaction [Oxaliplatin results in decreased expression of BCL2 mRNA]; naringin inhibits the reaction [Oxaliplatin results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] naringin results in decreased expression of BCL2 protein CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]]; naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]] naringin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]
|
CTD |
PMID:21945202 PMID:28422390 PMID:30130594 PMID:30878453 PMID:35166444 PMID:35179299 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
increases expression increases secretion multiple interactions
|
ISO EXP
|
naringin results in increased expression of BGLAP mRNA; naringin results in increased expression of BGLAP protein naringin results in increased secretion of BGLAP protein fulvestrant inhibits the reaction [naringin results in increased secretion of BGLAP protein]
|
CTD |
PMID:18495116 PMID:21741227 PMID:23596885 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
increases expression
|
ISO
|
naringin results in increased expression of BID protein
|
CTD |
PMID:39056589 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
multiple interactions decreases expression increases secretion increases expression
|
ISO EXP
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin promotes the reaction [FOS protein binds to BMP2 promoter]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin promotes the reaction [JUN protein binds to BMP2 promoter]]; FOS protein affects the reaction [naringin results in increased expression of BMP2 mRNA]; FOS protein affects the reaction [naringin results in increased expression of BMP2 protein]; JUN protein affects the reaction [naringin results in increased expression of BMP2 mRNA]; JUN protein affects the reaction [naringin results in increased expression of BMP2 protein]; naringin promotes the reaction [FOS protein binds to BMP2 promoter]; naringin promotes the reaction [JUN protein binds to BMP2 promoter] naringin results in decreased expression of BMP2 mRNA fulvestrant inhibits the reaction [naringin results in increased secretion of BMP2 protein] naringin results in increased expression of BMP2 mRNA; naringin results in increased expression of BMP2 protein
|
CTD |
PMID:18495116 PMID:21820093 PMID:23596885 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Bmp3
|
bone morphogenetic protein 3
|
decreases expression
|
ISO
|
naringin results in decreased expression of BMP3 mRNA
|
CTD |
PMID:18495116 |
|
NCBI chr14:11,012,564...11,041,282
Ensembl chr14:11,016,620...11,041,282
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
increases expression
|
ISO
|
naringin results in increased expression of BMP4 mRNA
|
CTD |
PMID:24915843 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Calcr
|
calcitonin receptor
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CALCR mRNA]
|
CTD |
PMID:21835177 |
|
NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:32,615,958...32,691,075
|
|
| G
|
Casp12
|
caspase 12
|
increases expression
|
ISO
|
naringin results in increased expression of CASP12 protein
|
CTD |
PMID:39056589 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
increases expression multiple interactions
|
ISO EXP
|
naringin results in increased expression of CASP3 mRNA naringin inhibits the reaction [Acetaminophen results in increased cleavage of CASP3 protein]; naringin inhibits the reaction [Acetaminophen results in increased expression of CASP3 protein modified form]; naringin inhibits the reaction [Acetaminophen results in increased expression of CASP3 protein]; naringin inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of CASP3 protein] Acetylcysteine inhibits the reaction [naringin results in increased expression of and results in increased cleavage of CASP3 protein]; naringin inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; naringin results in increased expression of and results in increased cleavage of CASP3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; naringin inhibits the reaction [3-nitropropionic acid results in increased cleavage of CASP3 protein]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]; naringin inhibits the reaction [Acrylamide results in increased expression of CASP3 protein]; naringin inhibits the reaction [Cisplatin results in increased expression of CASP3 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of CASP3 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; rottlerin inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]
|
CTD |
PMID:21945202 PMID:22847135 PMID:25773745 PMID:26612654 PMID:28422390 PMID:30130594 PMID:30878453 PMID:35166444 PMID:35179299 PMID:36598108 PMID:36811345 PMID:38037725 PMID:39056589 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
increases expression increases cleavage multiple interactions
|
ISO EXP
|
naringin results in increased expression of CASP9 mRNA naringin results in increased cleavage of CASP9 protein [bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of CASP9 protein]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein]; naringin inhibits the reaction [bisphenol A results in increased expression of CASP9 protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CASP9 protein]
|
CTD |
PMID:22847135 PMID:25773745 PMID:32172062 PMID:32428650 PMID:32810514 PMID:39056589 More...
|
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions
|
ISO EXP
|
naringin inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; naringin inhibits the reaction [Ferric Compounds results in decreased activity of CAT protein]; naringin inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein] naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; naringin inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; naringin inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; naringin inhibits the reaction [Cisplatin results in increased expression of CAT protein]; naringin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; naringin inhibits the reaction [nickel sulfate results in decreased activity of CAT protein]; naringin inhibits the reaction [Oxaliplatin results in decreased activity of CAT protein]
|
CTD |
PMID:20950607 PMID:21345335 PMID:21945202 PMID:22198281 PMID:25773745 PMID:26120027 PMID:26612654 PMID:29658312 PMID:33992719 PMID:36598108 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO EXP
|
naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]; naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] naringin inhibits the reaction [Cyclophosphamide results in increased expression of CCL2 mRNA]
|
CTD |
PMID:22965302 PMID:33992719 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL3 mRNA]; naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]
|
CTD |
PMID:22965302 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL5 protein]
|
CTD |
PMID:21500970 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
naringin results in decreased expression of CCND1 protein naringin inhibits the reaction [Dexamethasone results in increased expression of CCND1 mRNA] Acetylcysteine inhibits the reaction [naringin results in decreased expression of CCND1 protein]; naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CCND1 protein] naringin results in increased expression of CCND1 mRNA
|
CTD |
PMID:18296682 PMID:18951945 PMID:24915843 PMID:26482937 PMID:30878453 PMID:39056589 More...
|
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
decreases expression
|
ISO EXP
|
naringin results in decreased expression of CCNE1 protein
|
CTD |
PMID:18296682 PMID:18951945 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions decreases expression
|
EXP ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in decreased expression of CDK2 protein]; HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein]; naringin promotes the reaction [CDKN1A protein binds to CDK2 protein]; naringin results in decreased expression of and results in decreased activity of CDK2 protein; RAF1 protein affects the reaction [naringin results in decreased expression of CDK2 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of CDK2 protein]; Acetylcysteine inhibits the reaction [naringin results in decreased expression of CDK2 protein]; HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein]; naringin results in decreased expression of and results in decreased activity of CDK2 protein
|
CTD |
PMID:18296682 PMID:18951945 PMID:39056589 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of CDK4 protein]; HRAS protein affects the reaction [naringin results in decreased expression of CDK4 protein]; naringin promotes the reaction [CDKN1A protein binds to CDK4 protein]; naringin results in decreased expression of and results in decreased activity of CDK4 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in decreased expression of CDK4 protein]; HRAS protein affects the reaction [naringin results in decreased expression of CDK4 protein]; naringin promotes the reaction [CDKN1A protein binds to CDK4 protein]; naringin results in decreased expression of and results in decreased activity of CDK4 protein; RAF1 protein affects the reaction [naringin results in decreased expression of CDK4 protein]
|
CTD |
PMID:18296682 PMID:18951945 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of CDKN1A protein]; HRAS protein affects the reaction [naringin results in increased expression of CDKN1A protein]; naringin promotes the reaction [CDKN1A protein binds to CDK4 protein]; RAF1 protein affects the reaction [naringin results in increased expression of CDKN1A protein] naringin results in increased expression of CDKN1A mRNA; naringin results in increased expression of CDKN1A protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of CDKN1A protein]; HRAS protein affects the reaction [naringin results in increased expression of CDKN1A protein]; naringin promotes the reaction [CDKN1A protein binds to CDK2 protein]; naringin promotes the reaction [CDKN1A protein binds to CDK4 protein]; RAF1 protein affects the reaction [naringin results in increased expression of CDKN1A protein]
|
CTD |
PMID:18296682 PMID:18951945 PMID:39056589 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of CFTR mRNA]; naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of CFTR protein]
|
CTD |
PMID:31301536 |
|
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Chac2
|
ChaC glutathione specific gamma-glutamylcyclotransferase 2
|
multiple interactions
|
ISO
|
CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]]; CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of SOD2 protein]]; CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]]; CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of JUN protein]]; CHAC2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]]; CHAC2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of NFE2L2 protein]]; naringin inhibits the reaction [Acetaminophen results in decreased expression of CHAC2 protein]
|
CTD |
PMID:35166444 PMID:35179299 |
|
NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression
|
ISO
|
naringin results in increased expression of COL1A1 mRNA
|
CTD |
PMID:21741227 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions
|
ISO
|
[Dietary Fats co-treated with naringin] results in decreased expression of CPT1A mRNA
|
CTD |
PMID:22198281 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Csf1r
|
colony stimulating factor 1 receptor
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ATP6V0D2 mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CALCR mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CTSK mRNA]
|
CTD |
PMID:21835177 |
|
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
increases expression multiple interactions
|
ISO
|
naringin results in increased expression of CTNNB1 mRNA naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein]
|
CTD |
PMID:24915843 PMID:26482937 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctsb
|
cathepsin B
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in decreased activity of CTSB protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein]
|
CTD |
PMID:17188415 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsd
|
cathepsin D
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]
|
CTD |
PMID:17188415 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
| G
|
Ctsk
|
cathepsin K
|
multiple interactions decreases expression
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CTSK mRNA] naringin results in decreased expression of CTSK mRNA
|
CTD |
PMID:21835177 PMID:24376342 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
increases expression
|
EXP
|
naringin results in increased expression of CXCL12 protein
|
CTD |
PMID:29510123 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
affects expression
|
ISO
|
naringin affects the expression of CXCL2 mRNA
|
CTD |
PMID:25117567 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
increases expression
|
EXP
|
naringin results in increased expression of CXCR4 protein
|
CTD |
PMID:29510123 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [TNF protein results in increased expression of CYBA mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of CYBA protein]
|
CTD |
PMID:25391245 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [naringin results in decreased expression of CYCS protein]; naringin inhibits the reaction [Cadmium Chloride results in increased expression of CYCS protein] naringin results in increased expression of CYCS protein
|
CTD |
PMID:28422390 PMID:39056589 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp11b3
|
cytochrome P450, family 11, subfamily b, polypeptide 3
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [AGT protein results in increased expression of CYP11B2 mRNA]
|
CTD |
PMID:22798349 |
|
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921
|
|
| G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA]
|
CTD |
PMID:36598108 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
naringin results in decreased activity of CYP1A1 protein
|
CTD |
PMID:21053930 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
naringin results in decreased activity of CYP1A2 protein
|
CTD |
PMID:21053930 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
naringin binds to and results in decreased activity of CYP1B1 protein
|
CTD |
PMID:21053930 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases activity multiple interactions
|
ISO
|
naringin results in decreased activity of CYP3A4 protein naringin inhibits the reaction [CYP3A4 protein affects the metabolism of Verapamil]
|
CTD |
PMID:16013069 PMID:21053930 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
naringin results in increased expression of DDIT3 protein
|
CTD |
PMID:39056589 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Dhfr
|
dihydrofolate reductase
|
decreases activity
|
ISO
|
naringin results in decreased activity of DHFR protein
|
CTD |
PMID:25418905 |
|
NCBI chr 2:25,320,895...25,346,004
|
|
| G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
multiple interactions
|
ISO
|
DKK1 protein inhibits the reaction [naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA]]
|
CTD |
PMID:26482937 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
| G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [EGF protein affects the localization of RELA protein]; naringin inhibits the reaction [EGF protein results in increased expression of and results in increased phosphorylation of EGFR protein]; naringin inhibits the reaction [EGF protein results in increased expression of MUC5AC mRNA]; naringin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; naringin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; naringin inhibits the reaction [EGF protein results in increased secretion of MUC5AC protein]
|
CTD |
PMID:22766066 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [EGF protein results in increased expression of and results in increased phosphorylation of EGFR protein]
|
CTD |
PMID:22766066 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Oxaliplatin results in increased expression of EIF2AK3 mRNA]
|
CTD |
PMID:38037725 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Endog
|
endonuclease G
|
increases expression
|
ISO
|
naringin results in increased expression of ENDOG protein
|
CTD |
PMID:39056589 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions increases expression
|
EXP ISO
|
naringin inhibits the reaction [Oxaliplatin results in increased expression of ERN1 mRNA] naringin results in increased expression of ERN1 protein
|
CTD |
PMID:38037725 PMID:39056589 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions increases expression
|
EXP
|
fulvestrant inhibits the reaction [naringin results in increased expression of ESR1 mRNA]
|
CTD |
PMID:23596885 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions increases expression
|
EXP
|
fulvestrant inhibits the reaction [naringin results in increased expression of ESR2 mRNA]
|
CTD |
PMID:23596885 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]
|
CTD |
PMID:22198281 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Fadd
|
Fas associated via death domain
|
increases expression
|
ISO
|
naringin results in increased expression of FADD mRNA
|
CTD |
PMID:22847135 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
ISO
|
naringin results in increased expression of FAS mRNA
|
CTD |
PMID:22847135 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the activity of FASN protein]; naringin inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA]
|
CTD |
PMID:16427799 PMID:22198281 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
multiple interactions increases expression
|
EXP
|
fulvestrant inhibits the reaction [naringin results in increased expression of FGF2 mRNA]
|
CTD |
PMID:23596885 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin promotes the reaction [FOS protein binds to BMP2 promoter]]; FOS protein affects the reaction [naringin results in increased expression of BMP2 mRNA]; FOS protein affects the reaction [naringin results in increased expression of BMP2 protein]; naringin promotes the reaction [FOS protein binds to BMP2 promoter] naringin results in increased expression of FOS mRNA
|
CTD |
PMID:18495116 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Acrylamide results in decreased expression of FSHB protein]
|
CTD |
PMID:36598108 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the expression of G6PC1 mRNA]; naringin inhibits the reaction [Dietary Fats results in increased expression of G6PC1 mRNA]
|
CTD |
PMID:16427799 PMID:22198281 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
multiple interactions
|
EXP ISO
|
naringin inhibits the reaction [nickel sulfate results in decreased activity of G6PD protein] naringin affects the reaction [LEPR protein affects the activity of G6PD protein]
|
CTD |
PMID:16427799 PMID:20950607 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in increased activity of GAL protein]
|
CTD |
PMID:17188415 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Gck
|
glucokinase
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the expression of GCK mRNA]
|
CTD |
PMID:16427799 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression
|
EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of GCLC protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of GCLC protein]; [naringin co-treated with 3-nitropropionic acid] results in increased expression of GCLC mRNA; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein]; rottlerin inhibits the reaction [naringin results in increased expression of GCLC protein] naringin results in increased expression of GCLC mRNA; naringin results in increased expression of GCLC protein
|
CTD |
PMID:22871521 PMID:25773745 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Acetaminophen results in increased secretion of GOT1 protein]
|
CTD |
PMID:35166444 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP ISO
|
naringin affects the reaction [Cyclophosphamide affects the activity of GPT protein]; naringin inhibits the reaction [Oxaliplatin results in increased activity of GPT protein]; naringin inhibits the reaction [sodium arsenite results in increased expression of GPT protein] naringin inhibits the reaction [Acetaminophen results in increased secretion of GPT protein]; naringin inhibits the reaction [Doxorubicin results in increased expression of GPT protein]
|
CTD |
PMID:27174133 PMID:33992719 PMID:35166444 PMID:36811345 PMID:38037725 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
increases activity
|
ISO
|
naringin results in increased activity of GPX1 protein
|
CTD |
PMID:23603004 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP ISO
|
naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; naringin inhibits the reaction [Cyclophosphamide results in decreased activity of GSR protein]; naringin inhibits the reaction [nickel sulfate results in decreased activity of GSR protein] naringin inhibits the reaction [Mercuric Chloride results in decreased activity of GSR protein]
|
CTD |
PMID:20950607 PMID:21945202 PMID:23650045 PMID:33992719 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
increases expression multiple interactions
|
EXP
|
naringin results in increased expression of GSTP1 mRNA [naringin co-treated with 3-nitropropionic acid] results in increased expression of GSTP1 mRNA
|
CTD |
PMID:22871521 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gusb
|
glucuronidase, beta
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein]; naringin inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]
|
CTD |
PMID:17188415 |
|
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP ISO
|
naringin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] naringin affects the reaction [LEPR protein affects the activity of HMGCR protein]
|
CTD |
PMID:16427799 PMID:16906524 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression increases activity
|
ISO EXP
|
CHAC2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]]; naringin inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 protein]; naringin inhibits the reaction [Paraquat results in decreased expression of HMOX1 mRNA]; naringin inhibits the reaction [Paraquat results in decreased expression of HMOX1 protein]; naringin promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]; NFE2L2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]] naringin results in increased expression of HMOX1 mRNA; naringin results in increased expression of HMOX1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of HMOX1 protein]; [naringin co-treated with 3-nitropropionic acid] results in increased expression of HMOX1 mRNA; naringin inhibits the reaction [Oxaliplatin results in decreased expression of HMOX1 mRNA]; naringin inhibits the reaction [sodium arsenite results in decreased expression of HMOX1 mRNA]; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; rottlerin inhibits the reaction [naringin results in increased expression of HMOX1 protein] naringin results in increased activity of HMOX1 protein
|
CTD |
PMID:22871521 PMID:23603004 PMID:25773745 PMID:27174133 PMID:35166444 PMID:35179299 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
multiple interactions increases activity
|
ISO EXP
|
HRAS protein affects the reaction [naringin results in decreased expression of CDK2 protein]; HRAS protein affects the reaction [naringin results in decreased expression of CDK4 protein]; HRAS protein affects the reaction [naringin results in increased expression of CDKN1A protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] naringin results in increased activity of HRAS protein
|
CTD |
PMID:18296682 PMID:18951945 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions increases expression
|
EXP ISO
|
naringin inhibits the reaction [Oxaliplatin results in increased expression of HSPA5 mRNA] naringin results in increased expression of HSPA5 protein
|
CTD |
PMID:38037725 PMID:39056589 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions affects expression
|
ISO
|
naringin inhibits the reaction [Glucose results in increased expression of ICAM1]; naringin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] naringin inhibits the reaction [Acetaminophen results in increased expression of ICAM1 mRNA] naringin affects the expression of ICAM1 mRNA
|
CTD |
PMID:22074828 PMID:25117567 PMID:25391245 PMID:35166444 PMID:35179299 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Cyclophosphamide results in increased expression of IFNA1 mRNA]
|
CTD |
PMID:33992719 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions affects expression
|
ISO
|
naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] affects the localization of RELA protein]; naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL5 protein] naringin affects the expression of IFNG mRNA
|
CTD |
PMID:16945185 PMID:21500970 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
affects expression multiple interactions increases expression
|
EXP ISO
|
naringin affects the expression of IGF1 mRNA naringin inhibits the reaction [Dexamethasone results in increased expression of IGF1 mRNA] naringin results in increased expression of IGF1 mRNA fulvestrant inhibits the reaction [naringin results in increased expression of IGF1 mRNA]
|
CTD |
PMID:23596885 PMID:24880026 PMID:30878453 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions affects expression
|
EXP ISO
|
naringin inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of IL10 protein] naringin affects the expression of IL10 protein
|
CTD |
PMID:22985397 PMID:25117567 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il1b
|
interleukin 1 beta
|
affects expression multiple interactions
|
EXP ISO
|
naringin affects the expression of IL1B mRNA [bisphenol A co-treated with naringin] results in increased expression of IL1B protein; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of IL1B protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in increased expression of IL1B protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of IL1B protein]; naringin inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; naringin inhibits the reaction [bisphenol A results in increased expression of IL1B protein]; naringin inhibits the reaction [Cyclophosphamide results in increased expression of IL1B mRNA]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of IL1B protein]; naringin inhibits the reaction [Oxaliplatin results in increased expression of IL1B mRNA]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA] naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein] naringin inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; naringin inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]
|
CTD |
PMID:24131540 PMID:24880026 PMID:30130594 PMID:32172062 PMID:32428650 PMID:32810514 PMID:33992719 PMID:35166444 PMID:35179299 PMID:36598108 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Cyclophosphamide results in increased expression of IL1R1 mRNA]
|
CTD |
PMID:33992719 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il2
|
interleukin 2
|
affects expression
|
ISO
|
naringin affects the expression of IL2 protein
|
CTD |
PMID:25117567 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il4
|
interleukin 4
|
affects expression
|
ISO
|
naringin affects the expression of IL4 protein
|
CTD |
PMID:25117567 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
affects expression multiple interactions decreases expression
|
EXP ISO
|
naringin affects the expression of IL6 mRNA [naringin co-treated with Hesperidin] results in decreased expression of IL6 protein; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; naringin inhibits the reaction [Acrylamide results in increased expression of IL6 protein]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; naringin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] naringin results in decreased expression of IL6 protein naringin affects the expression of IL6 protein naringin inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA]; naringin inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]; naringin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]
|
CTD |
PMID:16137700 PMID:19810018 PMID:21820093 PMID:24131540 PMID:24880026 PMID:25117567 PMID:30130594 PMID:35166444 PMID:35179299 PMID:36598108 PMID:36811345 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions affects expression
|
ISO EXP
|
naringin inhibits the reaction [Nanotubes, Carbon inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; naringin promotes the reaction [Glucose results in increased secretion of INS1 protein] naringin affects the expression of INS1 protein
|
CTD |
PMID:24880026 PMID:29658312 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in decreased phosphorylation of IRS1 protein]
|
CTD |
PMID:22198281 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin promotes the reaction [JUN protein binds to BMP2 promoter]]; CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of JUN protein]]; JUN protein affects the reaction [naringin results in increased expression of BMP2 mRNA]; JUN protein affects the reaction [naringin results in increased expression of BMP2 protein]; naringin inhibits the reaction [Acetaminophen results in increased expression of JUN protein]; naringin promotes the reaction [JUN protein binds to BMP2 promoter]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of JUN protein]] naringin results in increased expression of JUN mRNA
|
CTD |
PMID:18495116 PMID:35166444 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Doxorubicin results in decreased expression of KEAP1 protein]
|
CTD |
PMID:36811345 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Lcat
|
lecithin cholesterol acyltransferase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]
|
CTD |
PMID:16906524 |
|
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in increased expression of LDHA protein]
|
CTD |
PMID:17188415 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldhb
|
lactate dehydrogenase B
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]
|
CTD |
PMID:17188415 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
|
|
| G
|
Lep
|
leptin
|
multiple interactions
|
ISO EXP
|
naringin inhibits the reaction [Dietary Fats results in increased expression of LEP protein] [naringin co-treated with Hesperidin] results in decreased expression of LEP protein; naringin inhibits the reaction [Glucose results in increased expression of LEP protein]
|
CTD |
PMID:21820093 PMID:22198281 PMID:24399619 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lepr
|
leptin receptor
|
multiple interactions
|
ISO EXP
|
naringin affects the reaction [LEPR protein affects the abundance of Glucose]; naringin affects the reaction [LEPR protein affects the activity of FASN protein]; naringin affects the reaction [LEPR protein affects the activity of G6PD protein]; naringin affects the reaction [LEPR protein affects the activity of HMGCR protein]; naringin affects the reaction [LEPR protein affects the expression of G6PC1 mRNA]; naringin affects the reaction [LEPR protein affects the expression of GCK mRNA]; naringin affects the reaction [LEPR protein affects the expression of PCK1 mRNA]; naringin affects the reaction [LEPR protein affects the expression of PPARG protein]; naringin affects the reaction [LEPR protein affects the expression of SLC2A2 protein]; naringin affects the reaction [LEPR protein affects the expression of SLC2A4 protein] naringin inhibits the reaction [Glucose results in increased expression of LEPR protein]
|
CTD |
PMID:16427799 PMID:24399619 |
|
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Acrylamide results in decreased expression of LHB protein]
|
CTD |
PMID:36598108 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Lpl
|
lipoprotein lipase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein]
|
CTD |
PMID:16906524 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Maoa
|
monoamine oxidase A
|
multiple interactions
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of MAOA protein; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased activity of MAOA protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of MAOA protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of MAOA protein]]; naringin inhibits the reaction [bisphenol A results in increased activity of MAOA protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of MAOA protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of MAOA protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions decreases phosphorylation increases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased phosphorylation of MAPK1 protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein]; naringin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein] naringin results in decreased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased phosphorylation of MAPK1 protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein] naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK1 protein]; naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK1 protein]; naringin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:18296682 PMID:18951945 PMID:21835177 PMID:22198281 PMID:22766066 PMID:22965302 PMID:25773745 PMID:26721195 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk10
|
mitogen activated protein kinase 10
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK10 protein]
|
CTD |
PMID:22198281 |
|
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Acrylamide results in increased expression of MAPK14 mRNA]
|
CTD |
PMID:36598108 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions decreases phosphorylation increases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased phosphorylation of MAPK3 protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein]; naringin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] naringin results in decreased phosphorylation of MAPK3 protein naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK3 protein]; naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK3 protein]; naringin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased phosphorylation of MAPK3 protein]; HRAS protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:18296682 PMID:18951945 PMID:21835177 PMID:22198281 PMID:22766066 PMID:22965302 PMID:25773745 PMID:26721195 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:22198281 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:22198281 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mir126a
|
microRNA 126a
|
multiple interactions increases expression
|
ISO
|
MIR126 mRNA affects the reaction [naringin results in decreased expression of VCAM1 mRNA] naringin results in increased expression of MIR126 mRNA
|
CTD |
PMID:24975661 |
|
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions
|
ISO
|
naringin results in decreased expression of and results in decreased activity of MMP2 protein
|
CTD |
PMID:26721195 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO EXP
|
naringin inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA]; naringin inhibits the reaction [Paraquat results in increased expression of MMP9 protein] naringin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; naringin results in decreased expression of and results in decreased activity of MMP9 protein naringin inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; naringin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; naringin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MMP9 protein]
|
CTD |
PMID:19810018 PMID:22985397 PMID:23603004 PMID:25866363 PMID:26721195 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Tobacco Smoke Pollution results in increased activity of MPO protein]
|
CTD |
PMID:22985397 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mt3
|
metallothionein 3
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Cadmium Chloride results in increased expression of MT3 protein]
|
CTD |
PMID:28422390 |
|
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [TNF protein results in increased phosphorylation of MTOR protein]
|
CTD |
PMID:19810018 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [EGF protein results in increased expression of MUC5AC mRNA]; naringin inhibits the reaction [EGF protein results in increased secretion of MUC5AC protein] naringin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased secretion of MUC5AC protein]
|
CTD |
PMID:22766066 PMID:31301536 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions affects localization
|
EXP ISO
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein]; [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein; naringin inhibits the reaction [Oxaliplatin results in decreased expression of NFE2L2 mRNA]; naringin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA]; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein]; rottlerin inhibits the reaction [naringin affects the localization of NFE2L2 protein] CHAC2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of NFE2L2 protein]]; naringin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]; naringin promotes the reaction [Acetaminophen results in increased expression of NFE2L2 protein]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of SOD2 protein]]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in increased expression of JUN protein]]; NFE2L2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]]; NFE2L2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of NFE2L2 protein]]; SIRT1 protein affects the reaction [naringin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]]
|
CTD |
PMID:22871521 PMID:25773745 PMID:27174133 PMID:35166444 PMID:35179299 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Cisplatin results in increased expression of NFKB1 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of NFKB1 mRNA]
|
CTD |
PMID:26120027 PMID:26612654 PMID:38037725 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
affects degradation multiple interactions
|
ISO
|
naringin affects the degradation of NFKBIA protein naringin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]
|
CTD |
PMID:21835177 PMID:25117567 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
affects expression multiple interactions
|
ISO EXP
|
naringin affects the expression of NOS2 mRNA naringin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] naringin inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]; naringin inhibits the reaction [Cisplatin results in increased expression of NOS2 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of NOS2 mRNA]
|
CTD |
PMID:16137700 PMID:22871521 PMID:25117567 PMID:26612654 PMID:38037725 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [TNF protein results in increased expression of NOX4 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of NOX4 protein]
|
CTD |
PMID:25391245 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions increases expression
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] results in increased expression of NQO1 mRNA naringin results in increased expression of NQO1 mRNA
|
CTD |
PMID:22871521 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
naringin results in increased cleavage of PARP1 protein
|
CTD |
PMID:39056589 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the expression of PCK1 mRNA]
|
CTD |
PMID:16427799 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of PDE5A protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of PDE5A protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein]]; naringin inhibits the reaction [bisphenol A results in increased activity of PDE5A protein]; naringin inhibits the reaction [Caffeine results in increased activity of PDE5A protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of PDE5A protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein]; naringin inhibits the reaction [potassium bromate results in increased activity of PDE5A protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 PMID:37865952 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dexamethasone results in increased expression of PIK3CA mRNA]
|
CTD |
PMID:30878453 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dexamethasone results in increased expression of PIK3R1 mRNA]
|
CTD |
PMID:30878453 |
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in decreased expression of PPARA mRNA]
|
CTD |
PMID:22198281 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO EXP
|
naringin affects the reaction [LEPR protein affects the expression of PPARG protein]; naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]; naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]
|
CTD |
PMID:16427799 PMID:22198281 PMID:30130594 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Ethanol results in increased expression of PPARGC1A mRNA]
|
CTD |
PMID:18793633 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
increases phosphorylation multiple interactions
|
EXP
|
naringin results in increased phosphorylation of PRKCD protein rottlerin inhibits the reaction [naringin results in increased phosphorylation of PRKCD protein]
|
CTD |
PMID:25773745 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
affects expression multiple interactions
|
ISO EXP
|
naringin affects the expression of PTGS2 mRNA; naringin affects the expression of PTGS2 protein naringin inhibits the reaction [Acetaminophen results in increased expression of PTGS2 protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of PTGS2 protein]; naringin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] naringin inhibits the reaction [3-nitropropionic acid results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:16137700 PMID:22871521 PMID:25117567 PMID:35166444 PMID:35179299 PMID:36811345 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Raf1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
multiple interactions increases activity increases phosphorylation
|
ISO EXP
|
RAF1 protein affects the reaction [naringin results in increased expression of CDKN1A protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] RAF1 protein affects the reaction [naringin results in decreased expression of CDK2 protein]; RAF1 protein affects the reaction [naringin results in decreased expression of CDK4 protein]; RAF1 protein affects the reaction [naringin results in increased expression of CDKN1A protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK1 protein]; RAF1 protein affects the reaction [naringin results in increased phosphorylation of MAPK3 protein] naringin results in increased activity of RAF1 protein naringin results in increased phosphorylation of RAF1 protein
|
CTD |
PMID:18296682 PMID:18951945 |
|
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] affects the localization of RELA protein]; naringin inhibits the reaction [EGF protein affects the localization of RELA protein] naringin affects the expression of and affects the activity of RELA protein; naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein]
|
CTD |
PMID:21500970 PMID:22766066 PMID:22965302 PMID:25117567 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [AICA ribonucleotide results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [cyanoginosin LR results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [Okadaic Acid results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KB1 protein]
|
CTD |
PMID:15342961 PMID:19810018 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
increases expression multiple interactions
|
ISO EXP
|
naringin results in increased expression of RUNX2 mRNA naringin inhibits the reaction [Dexamethasone results in decreased expression of RUNX2 protein] DKK1 protein inhibits the reaction [naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA]]; naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of RUNX2 mRNA] fulvestrant inhibits the reaction [naringin results in increased expression of RUNX2 mRNA]
|
CTD |
PMID:21741227 PMID:23596885 PMID:24915843 PMID:26482937 PMID:30878453 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
EXP ISO
|
naringin inhibits the reaction [Ethanol results in increased expression of SIRT1 mRNA] naringin inhibits the reaction [Doxorubicin results in decreased expression of SIRT1 protein]; SIRT1 protein affects the reaction [naringin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]]; SIRT1 protein affects the reaction [naringin inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]]
|
CTD |
PMID:18793633 PMID:36811345 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc2a2
|
solute carrier family 2 member 2
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the expression of SLC2A2 protein]
|
CTD |
PMID:16427799 |
|
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
multiple interactions
|
ISO
|
naringin affects the reaction [LEPR protein affects the expression of SLC2A4 protein]
|
CTD |
PMID:16427799 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slco1a1
|
solute carrier organic anion transporter family, member 1a1
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [SLCO1A1 protein results in increased uptake of perfluorooctanoic acid]
|
CTD |
PMID:19616083 |
|
NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992
|
|
| G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [SLCO1A2 protein alternative form results in increased uptake of estrone sulfate]; naringin inhibits the reaction [SLCO1A2 protein results in increased transport of estrone sulfate]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Quercetin]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Quinine]
|
CTD |
PMID:24947867 PMID:25466967 PMID:27504015 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
|
|
| G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; naringin inhibits the reaction [SLCO1B3 protein results in increased uptake of Hydroxyurea]
|
CTD |
PMID:21256917 PMID:22394605 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
| G
|
Smad3
|
SMAD family member 3
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [sodium arsenite results in increased expression of SMAD3 mRNA]
|
CTD |
PMID:27174133 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
ISO
|
CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of SOD2 protein]]; naringin inhibits the reaction [Acetaminophen results in decreased expression of SOD2 protein]; naringin inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]; naringin inhibits the reaction [Ferric Compounds results in decreased activity of SOD2 protein]; NFE2L2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of SOD2 protein]]
|
CTD |
PMID:21345335 PMID:35166444 PMID:35179299 PMID:36811345 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sp7
|
Sp7 transcription factor
|
increases expression multiple interactions
|
EXP ISO
|
naringin results in increased expression of SP7 mRNA naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SP7 mRNA] fulvestrant inhibits the reaction [naringin results in increased expression of SP7 mRNA]
|
CTD |
PMID:23596885 PMID:26482937 |
|
NCBI chr 7:135,363,193...135,373,376
Ensembl chr 7:135,363,199...135,373,559
|
|
| G
|
Spn
|
sialophorin
|
multiple interactions increases expression decreases expression
|
EXP
|
[bisphenol A co-treated with naringin] results in decreased expression of SPN protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in decreased expression of SPN protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in decreased expression of SPN protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of SPN protein]; naringin inhibits the reaction [bisphenol A results in increased expression of SPN protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of SPN protein] naringin results in increased expression of SPN protein naringin results in decreased expression of SPN protein
|
CTD |
PMID:32172062 PMID:32428650 |
|
NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:191,178,096...191,187,852
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression increases secretion multiple interactions
|
ISO EXP
|
naringin results in increased expression of SPP1 mRNA; naringin results in increased expression of SPP1 protein naringin results in increased secretion of SPP1 protein fulvestrant inhibits the reaction [naringin results in increased secretion of SPP1 protein]
|
CTD |
PMID:18495116 PMID:23596885 PMID:24915843 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:22198281 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Acrylamide results in decreased expression of STAR mRNA]
|
CTD |
PMID:36598108 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
affects expression
|
ISO
|
naringin affects the expression of STAT3 mRNA; naringin affects the expression of STAT3 protein
|
CTD |
PMID:25117567 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions affects expression
|
ISO EXP
|
naringin inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] naringin inhibits the reaction [Cyclophosphamide results in increased expression of TGFB1 mRNA]; naringin inhibits the reaction [sodium arsenite results in increased expression of TGFB1 mRNA] naringin affects the expression of TGFB1 mRNA
|
CTD |
PMID:23603004 PMID:25117567 PMID:27174133 PMID:33992719 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA]; naringin inhibits the reaction [Paraquat results in increased expression of TIMP1 protein]
|
CTD |
PMID:23603004 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions affects expression
|
ISO EXP
|
naringin inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; naringin inhibits the reaction [Dietary Fats results in increased expression of TNF protein]; naringin inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]; naringin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; naringin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF]; naringin inhibits the reaction [Paraquat results in increased expression of TNF mRNA] [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TNF protein]; naringin inhibits the reaction [Acrylamide results in increased expression of TNF protein]; naringin inhibits the reaction [bisphenol A results in increased expression of TNF protein]; naringin inhibits the reaction [Cisplatin results in increased expression of TNF mRNA]; naringin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TNF protein]; naringin inhibits the reaction [Oxaliplatin results in increased expression of TNF mRNA]; naringin inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; naringin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; naringin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]; naringin inhibits the reaction [TNF protein results in increased phosphorylation of MTOR protein]; naringin inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]; naringin inhibits the reaction [TNF protein results in increased secretion of IL6 protein]; naringin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNF protein] naringin affects the expression of TNF protein naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] affects the localization of RELA protein]; naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL5 protein]; naringin inhibits the reaction [TNF protein results in increased expression of CYBA mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of CYBA protein]; naringin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; naringin inhibits the reaction [TNF protein results in increased expression of NOX4 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of NOX4 protein]; naringin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] naringin affects the expression of TNF mRNA
|
CTD |
PMID:16137700 PMID:19810018 PMID:21500970 PMID:22198281 PMID:22871521 PMID:22985397 PMID:23603004 PMID:24131540 PMID:24880026 PMID:25117567 PMID:25391245 PMID:26120027 PMID:26612654 PMID:30130594 PMID:32172062 PMID:32428650 PMID:32810514 PMID:35166444 PMID:35179299 PMID:36598108 PMID:36811345 PMID:38037725 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11a
|
TNF receptor superfamily member 11A
|
decreases expression
|
ISO
|
naringin results in decreased expression of TNFRSF11A mRNA
|
CTD |
PMID:24376342 |
|
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:22,442,665...22,501,257
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B protein]; naringin inhibits the reaction [Dexamethasone results in increased expression of TNFRSF11B protein]
|
CTD |
PMID:30878453 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ATP6V0D2 mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CALCR mRNA]; naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of CTSK mRNA]; naringin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]; naringin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; naringin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:21835177 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
multiple interactions
|
EXP
|
naringin inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]
|
CTD |
PMID:17188415 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
naringin results in increased expression of TP53 mRNA naringin inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]; SIRT1 protein affects the reaction [naringin inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]] naringin results in decreased expression of TP53 protein [bisphenol A co-treated with naringin] results in decreased expression of TP53 protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in decreased expression of TP53 protein; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TP53 protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TP53 protein]; naringin inhibits the reaction [Acrylamide results in increased expression of TP53 mRNA]; naringin inhibits the reaction [bisphenol A results in increased expression of TP53 protein]; naringin inhibits the reaction [Cisplatin results in increased expression of TP53 mRNA]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TP53 protein]
|
CTD |
PMID:22847135 PMID:26120027 PMID:26612654 PMID:32172062 PMID:32428650 PMID:32810514 PMID:36598108 PMID:36811345 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tslp
|
thymic stromal lymphopoietin
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]
|
CTD |
PMID:24131540 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
multiple interactions
|
ISO
|
naringin inhibits the reaction [Dietary Fats results in increased expression of UCP2 mRNA]
|
CTD |
PMID:22198281 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions decreases expression
|
ISO
|
MIR126 mRNA affects the reaction [naringin results in decreased expression of VCAM1 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; naringin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] naringin results in decreased expression of VCAM1 mRNA; naringin results in decreased expression of VCAM1 protein
|
CTD |
PMID:24975661 PMID:25391245 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vegfc
|
vascular endothelial growth factor C
|
affects expression
|
EXP
|
naringin affects the expression of VEGFC mRNA
|
CTD |
PMID:24880026 |
|
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
|
|
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
multiple interactions
|
ISO
|
[neohesperidin co-treated with Dietary Fats] results in increased expression of ACAA2 mRNA
|
CTD |
PMID:32759940 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in increased expression of ACACA mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of ACOX1 mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
decreases expression
|
ISO
|
neohesperidin results in decreased expression of ACP5 mRNA
|
CTD |
PMID:27664516 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions
|
EXP ISO
|
neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK1 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK3 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of NPPB mRNA] neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK1 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK3 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of MYH7 mRNA]; neohesperidin inhibits the reaction [AGT protein results in increased expression of NOX4 mRNA]; neohesperidin inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]; neohesperidin inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]
|
CTD |
PMID:32531678 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Asip
|
agouti signaling protein
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [A mutant form results in increased expression of SCD1 mRNA]
|
CTD |
PMID:25620042 |
|
NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378
|
|
| G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
multiple interactions increases expression
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of BGLAP mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of BGLAP mRNA] neohesperidin results in increased expression of BGLAP mRNA; neohesperidin results in increased expression of BGLAP protein SNHG1 protein inhibits the reaction [neohesperidin results in increased expression of BGLAP mRNA]; SNHG1 protein inhibits the reaction [neohesperidin results in increased expression of BGLAP protein]
|
CTD |
PMID:34020675 PMID:34455928 PMID:34919014 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
increases expression decreases methylation multiple interactions
|
ISO
|
neohesperidin results in increased expression of BMP2 mRNA; neohesperidin results in increased expression of BMP2 protein neohesperidin results in decreased methylation of BMP2 promoter DKK1 protein inhibits the reaction [neohesperidin results in increased expression of BMP2 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of BMP2 mRNA]
|
CTD |
PMID:34020675 PMID:34919014 PMID:39067325 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of CAT mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL2 mRNA]
|
CTD |
PMID:39547268 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO
|
neohesperidin results in increased expression of CCND1 mRNA; neohesperidin results in increased expression of CCND1 protein
|
CTD |
PMID:34919014 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of CPT1A mRNA]
|
CTD |
PMID:28554169 PMID:32759940 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions affects localization increases expression
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of CTNNB1 mRNA]; neohesperidin results in increased expression of and results in decreased phosphorylation of CTNNB1 protein; XAV939 inhibits the reaction [neohesperidin results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] neohesperidin affects the localization of CTNNB1 protein
|
CTD |
PMID:34020675 PMID:34919014 PMID:39067325 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctsk
|
cathepsin K
|
decreases expression
|
ISO
|
neohesperidin results in decreased expression of CTSK mRNA
|
CTD |
PMID:27664516 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
multiple interactions
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of BGLAP mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of BMP2 mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of DLX5 mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of SPP1 mRNA] DKK1 protein inhibits the reaction [neohesperidin results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of LEF1 mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of MYC mRNA]; DKK1 protein inhibits the reaction [neohesperidin results in increased expression of TCF7 mRNA]
|
CTD |
PMID:34020675 PMID:34919014 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
| G
|
Dlx5
|
distal-less homeobox 5
|
multiple interactions increases expression
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of DLX5 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of DLX5 mRNA]
|
CTD |
PMID:34919014 |
|
NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA] neohesperidin inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of FASN mRNA]
|
CTD |
PMID:28554169 PMID:32759940 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fgf21
|
fibroblast growth factor 21
|
increases expression multiple interactions
|
ISO
|
neohesperidin results in increased expression of FGF21 mRNA neohesperidin promotes the reaction [Dietary Fats results in increased expression of FGF21 protein]
|
CTD |
PMID:28554169 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
affects expression
|
EXP
|
neohesperidin affects the expression of GFAP protein
|
CTD |
PMID:36331667 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in increased expression of GPT protein]
|
CTD |
PMID:32759940 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of GPX1 mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of HMGCR mRNA]
|
CTD |
PMID:28554169 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions decreases secretion
|
EXP
|
Anisomycin inhibits the reaction [neohesperidin results in decreased secretion of IFNG protein]
|
CTD |
PMID:33604646 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions
|
ISO
|
[Ascorbic Acid co-treated with neohesperidin co-treated with pycnogenols co-treated with Tocopherols co-treated with Hyaluronic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Vehicle Emissions] which results in increased expression of IL1A mRNA]
|
CTD |
PMID:35150043 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
affects expression multiple interactions
|
EXP ISO
|
neohesperidin affects the expression of IL1B protein neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1B mRNA]; neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1B protein]; neohesperidin inhibits the reaction [Dietary Fats results in increased expression of IL1B mRNA]
|
CTD |
PMID:32759940 PMID:36331667 PMID:39547268 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il27
|
interleukin 27
|
multiple interactions decreases secretion
|
EXP
|
Anisomycin inhibits the reaction [neohesperidin results in increased secretion of IL27 protein] neohesperidin results in decreased secretion of IL27 protein
|
CTD |
PMID:33604646 |
|
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions decreases secretion
|
EXP
|
Anisomycin inhibits the reaction [neohesperidin results in increased secretion of IL4 protein] neohesperidin results in decreased secretion of IL4 protein
|
CTD |
PMID:33604646 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions decreases secretion
|
ISO EXP
|
[Ascorbic Acid co-treated with neohesperidin co-treated with pycnogenols co-treated with Tocopherols co-treated with Hyaluronic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Vehicle Emissions] which results in increased expression of IL6 mRNA] neohesperidin results in decreased secretion of IL6 protein Anisomycin inhibits the reaction [neohesperidin results in decreased secretion of IL6 protein] neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 mRNA]; neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 protein]; neohesperidin inhibits the reaction [Dietary Fats results in increased expression of IL6 mRNA]
|
CTD |
PMID:32759940 PMID:33604646 PMID:35150043 PMID:39547268 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irf5
|
interferon regulatory factor 5
|
affects expression
|
EXP
|
neohesperidin affects the expression of IRF5 protein
|
CTD |
PMID:36331667 |
|
NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:59,081,357...59,112,552
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
neohesperidin results in increased expression of JUN mRNA; neohesperidin results in increased expression of JUN protein
|
CTD |
PMID:34919014 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Lef1
|
lymphoid enhancer binding factor 1
|
increases expression multiple interactions
|
ISO
|
neohesperidin results in increased expression of LEF1 mRNA; neohesperidin results in increased expression of LEF1 protein DKK1 protein inhibits the reaction [neohesperidin results in increased expression of LEF1 mRNA]
|
CTD |
PMID:34020675 PMID:34919014 |
|
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions affects phosphorylation
|
ISO EXP
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of MAPK1 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK1 protein] neohesperidin affects the phosphorylation of MAPK1 protein
|
CTD |
PMID:32531678 PMID:36331667 PMID:39547268 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions affects phosphorylation
|
ISO EXP
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of MAPK3 protein]; neohesperidin inhibits the reaction [AGT protein results in increased expression of MAPK3 protein] neohesperidin affects the phosphorylation of MAPK3 protein
|
CTD |
PMID:32531678 PMID:36331667 PMID:39547268 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in increased expression of MPO protein]
|
CTD |
PMID:32759940 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions increases expression
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of MYC mRNA] neohesperidin results in increased expression of MYC mRNA; neohesperidin results in increased expression of MYC protein
|
CTD |
PMID:34020675 PMID:34919014 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [AGT protein results in increased expression of MYH7 mRNA]
|
CTD |
PMID:32531678 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Nfatc1
|
nuclear factor of activated T-cells 1
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [TNFSF11 protein results in increased expression of and results in increased activity of NFATC1 protein]
|
CTD |
PMID:27664516 |
|
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of NFE2L2 mRNA]; SR18292 inhibits the reaction [neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of NFE2L2 mRNA]]
|
CTD |
PMID:32759940 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]
|
CTD |
PMID:27664516 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nog
|
noggin
|
multiple interactions
|
ISO
|
NOG protein inhibits the reaction [neohesperidin results in increased expression of BGLAP mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of BMP2 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of DLX5 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of SPP1 mRNA]
|
CTD |
PMID:34919014 |
|
NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [AGT protein results in increased expression of NOX4 mRNA]
|
CTD |
PMID:32531678 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Nppa
|
natriuretic peptide A
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]
|
CTD |
PMID:32531678 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
multiple interactions
|
ISO EXP
|
neohesperidin inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]
|
CTD |
PMID:32531678 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
P2rx4
|
purinergic receptor P2X 4
|
affects expression
|
EXP
|
neohesperidin affects the expression of P2RX4 mRNA; neohesperidin affects the expression of P2RX4 protein
|
CTD |
PMID:36331667 |
|
NCBI chr12:39,505,438...39,523,349
Ensembl chr12:39,505,438...39,523,094
|
|
| G
|
Pdk4
|
pyruvate dehydrogenase kinase 4
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of PDK4 mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions increases expression
|
ISO
|
neohesperidin inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARA protein] neohesperidin results in increased expression of PPARA mRNA neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of PPARA mRNA]; neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein]
|
CTD |
PMID:28554169 PMID:32759940 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
ISO
|
[neohesperidin co-treated with Dietary Fats] results in increased expression of PPARGC1A protein; neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of PPARGC1A mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 mRNA]; neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein]
|
CTD |
PMID:39547268 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions decreases phosphorylation
|
ISO EXP
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of RELA protein] neohesperidin results in decreased phosphorylation of RELA protein
|
CTD |
PMID:33604646 PMID:39547268 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
multiple interactions increases expression
|
ISO
|
SNHG1 protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 mRNA]; SNHG1 protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 protein] DKK1 protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of RUNX2 mRNA] neohesperidin results in increased expression of RUNX2 mRNA; neohesperidin results in increased expression of RUNX2 protein
|
CTD |
PMID:34020675 PMID:34455928 PMID:34919014 PMID:39067325 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [A mutant form results in increased expression of SCD1 mRNA]; neohesperidin inhibits the reaction [Dietary Fats results in increased expression of SCD1 mRNA]
|
CTD |
PMID:25620042 PMID:32759940 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Sirt1
|
sirtuin 1
|
increases expression
|
ISO
|
neohesperidin results in increased expression of SIRT1 protein
|
CTD |
PMID:28554169 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of SOD1 mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression multiple interactions
|
ISO
|
neohesperidin results in increased expression of SPP1 mRNA DKK1 protein inhibits the reaction [neohesperidin results in increased expression of SPP1 mRNA]; NOG protein inhibits the reaction [neohesperidin results in increased expression of SPP1 mRNA]
|
CTD |
PMID:34919014 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of SREBF1 mRNA] neohesperidin inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:28554169 PMID:32759940 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Tcf7
|
transcription factor 7
|
multiple interactions increases expression
|
ISO
|
DKK1 protein inhibits the reaction [neohesperidin results in increased expression of TCF7 mRNA] neohesperidin results in increased expression of TCF7 mRNA; neohesperidin results in increased expression of TCF7 protein
|
CTD |
PMID:34020675 PMID:34919014 |
|
NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of TFAM mRNA]; SR18292 inhibits the reaction [neohesperidin inhibits the reaction [Palmitic Acid results in decreased expression of TFAM mRNA]] neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of TFAM mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tnf
|
tumor necrosis factor
|
decreases secretion multiple interactions
|
EXP ISO
|
neohesperidin results in decreased secretion of TNF protein Anisomycin inhibits the reaction [neohesperidin results in decreased secretion of TNF protein] [Ascorbic Acid co-treated with neohesperidin co-treated with pycnogenols co-treated with Tocopherols co-treated with Hyaluronic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Vehicle Emissions] which results in increased expression of TNF mRNA] neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF mRNA]; neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF protein]; neohesperidin inhibits the reaction [Dietary Fats results in increased expression of TNF mRNA]
|
CTD |
PMID:32759940 PMID:33604646 PMID:35150043 PMID:39547268 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
affects expression
|
EXP
|
neohesperidin affects the expression of TNFRSF1A protein
|
CTD |
PMID:36331667 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]; neohesperidin inhibits the reaction [TNFSF11 protein results in increased expression of and results in increased activity of NFATC1 protein]
|
CTD |
PMID:27664516 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [Dietary Fats results in decreased expression of UCP2 mRNA]
|
CTD |
PMID:32759940 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO
|
neohesperidin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VEGFA protein]
|
CTD |
PMID:39547268 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR mRNA]; pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR protein]
|
CTD |
PMID:33393179 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
pinocembrin results in decreased activity of CYP19A1 protein
|
CTD |
PMID:38403145 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; pinocembrin promotes the reaction [Dasatinib inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]]
|
CTD |
PMID:33393179 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
pinocembrin results in decreased activity of CYP1A2 protein
|
CTD |
PMID:29753067 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
affects activity
|
ISO
|
pinocembrin affects the activity of CYP3A4 protein
|
CTD |
PMID:29753067 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased activity of GPT protein]
|
CTD |
PMID:33393179 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AX protein]
|
CTD |
PMID:33393179 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; pinocembrin inhibits the reaction [Ethanol results in increased phosphorylation of MAPK1 protein]; pinocembrin promotes the reaction [Dasatinib inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]]
|
CTD |
PMID:18295389 PMID:33393179 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]; pinocembrin inhibits the reaction [Ethanol results in increased phosphorylation of MAPK3 protein]; pinocembrin promotes the reaction [Dasatinib inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]]
|
CTD |
PMID:18295389 PMID:33393179 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of SRC protein]; pinocembrin promotes the reaction [Dasatinib inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of SRC protein]]
|
CTD |
PMID:33393179 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
increases sulfation
|
ISO EXP
|
SULT1A1 protein results in increased sulfation of pinocembrin
|
CTD |
PMID:11181495 |
|
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
|
|
| G
|
Tgm2
|
transglutaminase 2
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Ethanol results in increased activity of TGM2 protein]; pinocembrin inhibits the reaction [Ethanol results in increased expression of TGM2 mRNA]
|
CTD |
PMID:18295389 |
|
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TP53BP1 protein] pinocembrin inhibits the reaction [Benzo(a)pyrene results in increased expression of TRP53BP1 protein]
|
CTD |
PMID:33393179 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
decreases activity
|
ISO
|
sakuranetin results in decreased activity of CYP19A1 protein
|
CTD |
PMID:38403145 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases activity
|
ISO
|
sophoranone results in decreased activity of CYP2C19 protein
|
CTD |
PMID:29753067 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity
|
ISO
|
sophoranone results in decreased activity of CYP2D6 protein
|
CTD |
PMID:29753067 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
sophoranone results in decreased activity of CYP3A4 protein
|
CTD |
PMID:29753067 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|